Park Ha Biological Technology Co
BYAH
2 hedge funds and large institutions have $54.3K invested in Park Ha Biological Technology Co in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
53,632% more capital invested
Capital invested by funds: $101 → $54.3K (+$54.2K)
2.55% more ownership
Funds ownership: 0% → 2.55% (+2.5%)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$34.3K |
| 2 |
Morgan Stanley
New York
|
+$30.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$84 |
BYAH Hedge Fund Activity: Q2 2026 in Review
2 of the 8,343 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology Co (BYAH) for Q2 2026, worth a combined $54.3K — up 53,632% from $101 a quarter earlier.
Fund positioning in BYAH was balanced in Q2 2026: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $34.3K. The largest seller was UBS Group, exiting entirely with an estimated $84 sold.
- 2 institutional investors held Park Ha Biological Technology Co (BYAH) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $54.3K of Park Ha Biological Technology Co stock for Q2 2026, up 53,632% quarter-over-quarter.
- 1 fund opened new Park Ha Biological Technology Co positions in Q2 2026 and 1 closed out, a net change of 0 holders.
- The largest Park Ha Biological Technology Co buyer in Q2 2026 was Virtu Financial, an estimated $34.3K added.
- The largest Park Ha Biological Technology Co seller in Q2 2026 was UBS Group, an estimated $84 sold.
Based on aggregated 13F filings for Q2 2026.